All Posts in Category: Uncategorized

PACEOMICS at the 2016 CADTH Symposium

Links to the following presentations HERE

Paulden, M., O’Mahony, J., and McCabe, C. The determinants of change in the cost-effectiveness threshold.

Akude, P., Mahjoub, R., Paulden, M., and McCabe, C. A framework for cost-effectiveness analysis of Personalized Medicine co-dependent technologies. 

Paulden, M., O’Mahony, J., and McCabe, C. Decision rules for value-based reimbursement: Moving on from ‘net health benefit.’ (poster)

 

Read More

Ground-breaking settlement changes landscape for genetic medicine in Canada

CHEO and Transgenomic reach agreement on Long QT patents that sets pathway for next generation of patient care

Professor Richard Gold, who leads the Intellectual Asset Management stream within PACEOMICS and is a James McGill Professor at McGill University’s Faculty of Law, advised the Children’s Hospital of Eastern Ontario (CHEO) on policy aspects of the case.

PRESS RELEASE

MEDIA (selected)

CHEO reaches ‘historic’ settlement with gene patent owner (CBCNews)

Ont. hospital reaches settlement over gene patents (CTVNews)

The genetic test you couldn’t get in Canada, until now (Global News)

CHEO reaches landmark agreement to knock gene patents out of the way of healthcare (Ottawa Citizen)

Read More